This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., National Institute for Agricultural Research, The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center. Active years: 2007-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 915 
1 out of 285 
1 out of 60 Years Active: 2007-2015
Title: Arieh Gertler: Innovator in Leptin Research
Introduction
Arieh Gertler is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of biomedical research, particularly in the study of leptin and its receptors. With a total of 3 patents, Gertler's work has implications for various medical applications.
Latest Patents
Gertler's latest patents include innovative developments in leptin research. One of his patents focuses on high affinity leptins and leptin antagonists. These leptin muteins, particularly the antagonists, exhibit increased binding affinity to the leptin receptor. This advancement is crucial for treating disorders where the undesirable activity of endogenous leptin or an altered innate immune response is involved. Another significant patent involves leptin binding domain compositions and methods. This invention provides compositions and methods related to avian leptin receptor binding domains. It demonstrates utility in detecting the presence of leptin in samples and distinguishing between free and bound leptin across multiple species. Methods and kits are also presented for determining free leptin in a sample by assaying the binding of leptin to an avian leptin receptor binding domain.
Career Highlights
Throughout his career, Gertler has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Universités Paris 6 et Paris 7. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Gertler has collaborated with notable colleagues, including Isabelle Callebaut and Jean Djiane. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Arieh Gertler's innovative work in leptin research has led to significant advancements in understanding and treating related disorders. His contributions continue to influence the field and pave the way for future discoveries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile